A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy

Jingya Zhao; Huabei Huang; Jinyan Zhao; Xiang Xiong; Sibo Zheng; Xiaoqing Wei; Shaobing Zhou

doi:10.1016/j.apsb.2021.10.019

A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy

doi: 10.1016/j.apsb.2021.10.019

Key Laboratory of Advanced Technologies of Materials, Ministry of Education, School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China

基金项目:

This study was supported by the National Natural Science Foundation of China (51725303, 81701831, 52033007), the Sichuan Science and Technology Program (2020YFH0046, China) and the Fundamental Research Funds for the Central Universities (2682021CG017, China). The authors thank Analytical and Testing Center of Southwest Jiaotong University.

详细信息

通讯作者:
Shaobing Zhou,E-mail:shaobingzhou@swjtu.edu.cn

中图分类号: https://www.sciencedirect.com/science/article/pii/S2211383521004111/pdf?md5=1c740b2c325d0300ee1951067feeea53&pid=1-s2.0-S2211383521004111-main.pdf
计量
- 文章访问数: 41
- HTML全文浏览量: 23
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2021-08-08
- 修回日期: 2021-09-18
- 录用日期: 2021-10-15
- 网络出版日期: 2023-03-17

A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy

Key Laboratory of Advanced Technologies of Materials, Ministry of Education, School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China

Funds:

摘要

摘要: Remodeling the tumor microenvironment through reprogramming tumor-associated macrophages (TAMs) and increasing the immunogenicity of tumors via immunogenic cell death (ICD) have been emerging as promising anticancer immunotherapy strategies. However, the heterogeneous distribution of TAMs in tumor tissues and the heterogeneity of the tumor cells make the immune activation challenging. To overcome these dilemmas, a hybrid bacterium with tumor targeting and penetration, TAM polarization, and photothermal conversion capabilities is developed for improving antitumor immunotherapy in vivo. The hybrid bacteria (B.b@QDs) are prepared by loading Ag₂S quantum dots (QDs) on the Bifidobacterium bifidum (B.b) through electrostatic interactions. The hybrid bacteria with hypoxia targeting ability can effectively accumulate and penetrate the tumor tissues, enabling the B.b to fully contact with the TAMs and mediate their polarization toward M1 phenotype to reverse the immunosuppressive tumor microenvironment. It also enables to overcome the intratumoral heterogeneity and obtain abundant tumor-associated antigens by coupling tumor penetration of the B.b with photothermal effect of the QDs, resulting in an enhanced immune effect. This strategy that combines B.b-triggered TAM polarization and QD-induced ICD achieved a remarkable inhibition of tumor growth in orthotopic breast cancer.
- Immunotherapy /
- Tumor-associated macrophage /
- Immunogenic cell death /
- Bifidobacterium /
- Quantum dot
Abstract: Remodeling the tumor microenvironment through reprogramming tumor-associated macrophages (TAMs) and increasing the immunogenicity of tumors via immunogenic cell death (ICD) have been emerging as promising anticancer immunotherapy strategies. However, the heterogeneous distribution of TAMs in tumor tissues and the heterogeneity of the tumor cells make the immune activation challenging. To overcome these dilemmas, a hybrid bacterium with tumor targeting and penetration, TAM polarization, and photothermal conversion capabilities is developed for improving antitumor immunotherapy in vivo. The hybrid bacteria (B.b@QDs) are prepared by loading Ag₂S quantum dots (QDs) on the Bifidobacterium bifidum (B.b) through electrostatic interactions. The hybrid bacteria with hypoxia targeting ability can effectively accumulate and penetrate the tumor tissues, enabling the B.b to fully contact with the TAMs and mediate their polarization toward M1 phenotype to reverse the immunosuppressive tumor microenvironment. It also enables to overcome the intratumoral heterogeneity and obtain abundant tumor-associated antigens by coupling tumor penetration of the B.b with photothermal effect of the QDs, resulting in an enhanced immune effect. This strategy that combines B.b-triggered TAM polarization and QD-induced ICD achieved a remarkable inhibition of tumor growth in orthotopic breast cancer.
- Immunotherapy /
- Tumor-associated macrophage /
- Immunogenic cell death /
- Bifidobacterium /
- Quantum dot

HTML全文

参考文献(44)

[1]	Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. The future of cancer treatment:immunomodulation, CARs and combination immunotherapy. Nat Rev Clin Oncol 2016;13:273-290
[2]	Nam J, Son S, Park KS, Zou WP, Shea LD, Moon JJ. Cancer nanomedicine for combination cancer immunotherapy. Nat Rev Mater 2019;4:398-414
[3]	O'Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol 2019;16:151-167
[4]	Farhood B, Najafi M, Mortezaee K. CD8⁺ cytotoxic T lymphocytes in cancer immunotherapy:a review. J Cell Physiol 2019;234:8509-8521
[5]	Munn DH, Bronte V. Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol 2016;39:1-6
[6]	Zhou JW, Tang ZW, Gao SY, Li CY, Feng YT, Zhou XK. Tumor-associated macrophages:recent insights and therapies. Front Oncol 2020;10:188
[7]	Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, et al. Immune cells within the tumor microenvironment:biological functions and roles in cancer immunotherapy. Cancer Lett 2020;470:126-133
[8]	Liu Y, Cao XT. The origin and function of tumor-associated macrophages. Cell Mol Immunol 2015;12:1-4
[9]	Chen YB, Song YC, Du W, Gong LL, Chang HC, Zou ZZ. Tumor-associated macrophages:an accomplice in solid tumor progression. J Biomed Sci 2019;26:78
[10]	Lin YX, Xu JX, Lan HY. Tumor-associated macrophages in tumor metastasis:biological roles and clinical therapeutic applications. J Hematol Oncol 2019;12:76
[11]	Anfray C, Ummarino A, Andon FT, Allavena P. Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses. Cells 2020;9:46
[12]	Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 2017;14:399-416
[13]	Wei B, Pan J, Yuan R, Shao B, Wang Y, Guo X, et al. Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy. Nano Lett 2021;21:4231-4240
[14]	Liu L, Wang Y, Guo X, Zhao J, Zhou S. A biomimetic polymer magnetic nanocarrier polarizing tumor-associated macrophages for potentiating immunotherapy. Small 2020;16:2003543
[15]	Rodell CB, Arlauckas SP, Cuccarese MF, Garris CS, Ahmed RLMS, Kohler RH, et al. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat Biomed Eng 2018;2:578-588
[16]	Li DD, Zhang M, Xu F, Chen YZ, Chen BF, Chang Y, et al. Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation. Acta Pharm Sin B 2018;8:74-84
[17]	Yi C, Huang Y, Guo ZY, Wang SR. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin 2005;26:629-634
[18]	Luo CH, Huang CT, Su CH, Yeh CS. Bacteria-mediated hypoxia-specific delivery of nanoparticles for tumors imaging and therapy. Nano Lett 2016;16:3493-3499
[19]	Chen WF, Wang Y, Qin M, Zhang XD, Zhang ZR, Sun X, et al. Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy. ACS Nano 2018;12:5995-6005
[20]	Chen FM, Zang ZS, Chen Z, Cui L, Chang ZG, Ma AQ, et al. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials 2019;214:119226
[21]	Fang J, Islam W, Maeda H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv Drug Deli Rev 2020;157:142-160
[22]	Felfoul O, Mohammadi M, Taherkhani S, Lanauze DD, Xu YZ, Loghin D, et al. Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions. Nat Nanotechnol 2016;11:941-947
[23]	Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol 2016;7:1204
[24]	Wang F, Yin Q, Chen L, Davis MM. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade. Proc Natl Acad Sci U S A 2018;115:157-161
[25]	Matson V, Fessler J, Bao R, Chongsuwat T, Zha YY, Alegre ML, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 2018;359:104-108
[26]	Shi YY, Zheng WX, Yang KT, Harris KG, Ni KY, Xue L, et al. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med 2020;217:20192282
[27]	Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015;350:1084-1089
[28]	Huang LP, Li YN, Du YN, Zhang YY, Wang XX, Y. et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nat Commun 2019;10:4871
[29]	Ma YC, Zhang YX, Li XQ, Zhao YY, Li M, Jiang W, et al. Near-infrared II phototherapy induces deep tissue immunogenic cell death and potentiates cancer immunotherapy. ACS Nano 2019;13:11967-11980
[30]	Sweeney EE, Cano-Mejia J, Fernandes R. Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma. Small 2018;14:1800678
[31]	Zhou ZW, Wu H, Yang RX, Xu A, Zhang QY, Dong JW, et al. GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer. Sci Adv 2020;6:4373
[32]	Xu Z, Huang HB, Xiong X, Wei XQ, Guo X, Zhao JY, et al. A near-infrared light-responsive extracellular vesicle as a "Trojan horse" for tumor deep penetration and imaging-guided therapy. Biomaterials 2021;269:120647
[33]	Xiong X, Xu Z, Huang HB, Wang Y, Zhao JY, Guo X, et al. A NIR light triggered disintegratable nanoplatform for enhanced penetration and chemotherapy in deep tumor tissues. Biomaterials 2020;245:119840
[34]	Liu R, Hu C, Yang YY, Zhang JQ, Gao HL. Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 2019;9:410-420
[35]	Yang Y, Zhu WJ, Dong ZL, Chao Y, Xu L, Chen MW, et al. 1D coordination polymer nanofibers for low-temperature photothermal therapy. Adv Mater 2017;29:1703588
[36]	Sun T, Zhang GP, Wang QB, Chen QJ, Chen XL, Lu YF, et al. A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion. Biomaterials 2018;183:268-279
[37]	Li XM, Zhang YH, Ma ZQ, He CJ, Wu YL, An Q, et al. Designing cancer nanodrugs that are highly loaded, pH-responsive, photothermal, and possess a favored morphology:a hierarchical assembly of DOX and layer-by-layer modified rGO. Chin Chem Lett 2019;30:489-493
[38]	Zhao JY, Zhong D, Zhou SB. NIR-I-to-NIR-II fluorescent nanomaterials for biomedical imaging and cancer therapy. J Mater Chem B 2018;6:349-365
[39]	Yang T, Tang YA, Liu L, Lv XY, Wang QL, Ke HT, et al. Size-dependent Ag₂S nanodots for second near-infrared fluorescence/photoacoustics imaging and simultaneous photothermal therapy. ACS Nano 2017;11:1848-1857
[40]	Aydemir D, Hashemkhani M, Durmusoglu EG, Acar HY, Ulusu NN. A new substrate for glutathione reductase:glutathione coated Ag₂S quantum dots. Talanta 2019;194:501-506
[41]	Hu QL, Wu M, Fang C, Cheng CY, Zhao MM, Fang WH, et al. Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy. Nano Lett 2015;15:2732-2739
[42]	Tang H, Xu X, Chen Y, Xin H, Wan T, Li B, et al. Reprogramming the tumor microenvironment through second-near-infrared-window photothermal genome editing of PD-L1 mediated by supramolecular gold nanorods for enhanced cancer immunotherapy. Adv Mater 2021;33:2006003
[43]	Wei X, Liu LQ, Li XL, Wang Y, Guo X, Zhao JY, et al. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy. J Control Release 2019;313:42-53
[44]	He LZ, Nie TQ, Xia XJ, Liu T, Huang YY, Wang XJ, et al. Designing bioinspired 2D MoSe₂ nanosheet for efficient photothermal-triggered cancer immunotherapy with reprogramming tumor-associated macrophages. Adv Funct Mater 2019;29:1901240

施引文献

资源附件(0)

访问统计

点击查看大图

计量

文章访问数: 41
HTML全文浏览量: 23
PDF下载量: 0
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy

doi: 10.1016/j.apsb.2021.10.019

通讯作者:
Shaobing Zhou,E-mail:shaobingzhou@swjtu.edu.cn

计量

A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy

计量

目录

留言板

A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy

doi: 10.1016/j.apsb.2021.10.019

通讯作者: Shaobing Zhou,E-mail:shaobingzhou@swjtu.edu.cn

计量

出版历程

A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy

计量

出版历程

目录

通讯作者:
Shaobing Zhou,E-mail:shaobingzhou@swjtu.edu.cn